2009 Deloitte Technology Fast 500 Asia Pacific award for Sundia MediTech Sundia MediTech.


This award reflects our sustained growth over the past several years specifically in the global financial and economical turmoil. .. 2009 Deloitte Technology Fast 500 Asia Pacific award for Sundia MediTech Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, today that the business provides received 2009 Deloitte Technology Fast 500 Asia Pacific award announced. This is Sundia’s 2nd consecutive calendar year to win this award. On December 10 The news was announced at a ceremony, 2009 at the Intercontinental Resort in Hong Kong. The Deloitte Technology Fast 500 Asia Pacific program is in its eighth year now. The program recognizes the fastest-growing technology businesses from countries across the Asia Pacific region including Australia, China/Hong Kong, India, Japan and several other countries.

People, using the KnowledgePanel through a partnership with GfK Custom Research North America. Participants weren’t asked about their spiritual or political affiliations. In this study, females, blacks, and Hispanics were more likely to support coverage of birth control medications than were males, older individuals and adults without children in the real home. Basically, support is normally higher among individuals who may be much more likely to straight reap the benefits of affordable contraceptive, says Moniz, who’s also an associate of U-M's Institute for Healthcare Plan and Innovation. Understanding public views upon this issue is quite crucial to medical and open public health efforts to reduce unplanned pregnancy in the U.S.People, using the KnowledgePanel through a partnership with GfK Custom Research North America. Participants weren’t asked about their spiritual or political affiliations. In this study, females, blacks, and Hispanics were more likely to support coverage of birth control medications than were males, older individuals and adults without children in the real home. Basically, support is normally higher among individuals who may be much more likely to straight reap the benefits of affordable contraceptive, says Moniz, who’s also an associate of U-M's Institute for Healthcare Plan and Innovation. Understanding public views upon this issue is quite crucial to medical and open public health efforts to reduce unplanned pregnancy in the U.S.